Chaperone-assisted E3 ligase CHIP: A double agent in cancer
Authors:
Open Access
- 1 September 2021
- journal article
- review article
- Published by Elsevier in Genes & Diseases
- Vol. 9 (6) , 1521-1555
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (DST/NM/NT/2018/105)
- Council of Scientific and Industrial Research, India
- Anusandhan National Research Foundation (31-2(274)2020-21/Bud-II)
- Anusandhan National Research Foundation (EMR/2017/000992)
This publication has 490 references indexed in Scilit:
- Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differencesCellular and Molecular Life Sciences, 2013
- Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph DiseaseFrontiers in Neurology, 2013
- A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsCancer Chemotherapy and Pharmacology, 2011
- Versatile TPR domains accommodate different modes of target protein recognition and functionCell Stress and Chaperones, 2011
- Tau protein degradation is catalyzed by the ATP/ubiquitin-independent 20S proteasome under normal cell conditionsArchives of Biochemistry and Biophysics, 2010
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Phase I study of 17-allylamino-17 demethoxygeldanamycin, gemcitabine and/or cisplatin in patients with refractory solid tumorsInvestigational New Drugs, 2010
- Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal DegradationCell, 2009
- Quercetin‐induced ubiquitination and down‐regulation of Her‐2/neuJournal of Cellular Biochemistry, 2008
- Structural Insights into E1-Catalyzed Ubiquitin Activation and Transfer to Conjugating EnzymesCell, 2008